Artificial Intelligence
REGO Payment Architectures, Inc. Issues Shareholder Letter and Provides Corporate Update
BLUE BELL, Pa., Jan. 30, 2020 (GLOBE NEWSWIRE) — REGO Payment Architectures, Inc. (“REGO”) (OTCQB: RPMT) today issued a letter to its shareholders from Chief Financial Officer Scott McPherson.
Dear Shareholders,
REGO’s corporate and technical progress in 2019 was both significant and substantial. The company streamlined its strategy to leverage its data control and identity management features. Highlighting these security and privacy discriminators allowed us to communicate how these essential building blocks in our architecture position us to offer our completely all-digital family wallet solution in the marketplace globally. As many are familiar, this technology is essential to enable the under 18-year-old age group to transact and socialize in a secure online environment guided by parental permission, oversight, and control.
During the summer of 2019, our technical development of a working demo successfully executed a live transaction and yields a Children’s Online Privacy Protection Act (COPPA) and EU General Data Protection Regulation (GDPR) compliant data set was a watershed milestone. The significance of the demo version of our application, currently able to be shown on Android, iPhone, and Amazon Fire, is unequivocal. The REGO platform opens up a COPPA/GDPR compliant payment gateway that currently does not exist for the parent and the child to execute on device purchases. The ability for this gateway to supplement existing content and services, as well as the ability to enhance data capture for parents, retailers, and other interested parties is significantly different from other current market offerings.
Technology & Customer Discussions
Throughout the past year, we made many changes to our enterprise architecture to position the offering for a product release in 2020. We replaced the card program manager and updated our code to utilize the new card manager’s API to move currency. We also replaced the issuing bank. These moves culminated with our announcement on January 14, 2020, of our partnership with Cornerstone Payment Systems, Inc. to extend the platform’s payment processing options—thereby solidifying all the financial infrastructure partnerships we needed to move towards a viable product.
In addition, we moved our platform from Amazon Web Services (AWS) to Microsoft Azure, conducted independent third-party tests of our application performance (receiving high marks), and finally, we renewed COPPA certification by PRIVO (a safe harbor and identity and consent service provider) in July 2019. Additionally, GDPR certification is underway and should be completed during the first quarter of 2020.
As we move through 2020, our main focus is to release the initial version of the platform. REGO announced on January 20, 2020, that it will be working with Blue Diamond Media to provide its anchor product, REGO Digital Wallet, to Blue Diamond Media’s network of customers. A roll-out plan has been delivered to Blue Diamond Media which outlines a swift trajectory from a pilot program to network-wide adoption throughout the year. This will be a significant opportunity for customer feedback and feature acceleration, as well as the ability for the platform to be more fully understood in the marketplace.
As we move forward, we expect our multi-pronged business model to provide REGO with the flexibility to drive sustainable revenues over the long-term. Among these options are potentially a technology licensing model, joint venture concepts, and white labeling to take advantage of significant business to business opportunity sets.
Continued Innovation
In addition to the launch of the product, we have formed the analytics division to distribute COPPA/GDPR certified data sets. The demand for a more stringent eye on privacy protection is on the rise and the data generated by the REGO platform is becoming all the more consequential. The proprietary data sets we generate specifically address COPPA/GDPR compliance and showcase the geography and age range of the purchaser. Our ability to forecast aggregate data clusters by location, age, payment, product, brand, and transaction data is one-of-a-kind.
Enhanced Branding Initiatives
In 2020, we are implementing initiatives to increase market awareness of our launch and subsequent successes. We have engaged branding and marketing specialists, One Kiln Marketing, to lead a comprehensive branding and communications program. Thus far, the firm has developed marketing assets for demonstration including slick sheet, logo development, and assisted in the development of the 90-day launch roll-out plan with Blue Diamond Media. We also plan to conduct a comprehensive revision of our corporate website—in the meantime, a new splash page is currently active.
REGO was featured in the January 2020 edition of Armed Forces Communications and Electronics Association’s (AFCEA) SIGNAL magazine, a defense communications and electronics publication, in which REGO was spotlighted for its ability to address a financial solution for remote military families. Also, our investment banker, SKB Capital, conducted a podcast interview highlighting REGO with the financial publication Wall Street Analyzer.
During 2020, we also intend to increase our interface with the capital markets – details forthcoming. To assist with these efforts, we retained Morgan, Lewis & Bockius LLP and SKB Capital.
Final Thoughts
In closing, the most consistent question we receive from investors, partners, and potential customers is – “why is REGO the only company able to deliver an all-digital COPPA/GDPR compliant family wallet?” I think it is important to offer my thoughts on this especially as we are about to engage the market with the REGO platform:
There is a fair amount of the REGO platform that is easily duplicated/commoditized— for example, the app skin, APIs to retailers, APIs to financial infrastructure, and cloud storage. But, just how defensible our market positioning remains, in the long run, rests on three defining factors:
1. | The ability to define data control settings from parent to child. |
REGO approaches this problem using a master account to dictate purchase rules to sub-accounts via a hierarchical architecture – REGO has patent-protected this data control methodology. This approach adheres to data flow and privacy policy requirements specifically outlined for COPPA compliance. We believe other approaches based on machine learning (or other artificial intelligence) methodologies are potentially viable alternatives but are likely too costly, do not meet current compliance timelines, and may defy the core of COPPA’s “opt-in” parameters. That being said, there is plenty of room for next-generation automation techniques to be layered on REGO’s hierarchical approach. Given its current stability and scalability metrics, REGO strongly features these advances in its tech development roadmap —without compromising any of its current data control performance.
2. | The ability to (mis)attribute the child’s transaction and personal identification. |
REGO has solved this hard problem by masking user data and maintaining separate identity and financial data flows— REGO has patent-protected this attribution methodology. As a result, REGO can verify the age of the internet user throughout the transaction lifecycle on its platform. Authenticating and validating the identity of the actual user on the internet maintains one of the hardest cybersecurity problems. Current world-class approaches are mainly not for commercial use; however, there is investment in commercial innovation in this area. Even so, we see the power of REGO’s data control features and its (mis)attribution approach as inextricably linked and a key to its scalability and extensibility.
3. | The ability to disseminate transactional data on minors. |
COPPA/GDPR compliant data can be disseminated, used, and sold. The highest value data will be that which shows the most nuanced detail afforded under current regulations. Without extreme data control features, such as in the REGO platform, any lesser data precision will thus be less valuable.
I see this rationale as the most fundamental reason why REGO is in position to create sustainable, long-term value for our shareholders.
Safe Harbor Statement
This document contains forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from our expectations include, but are not limited to: our ability to raise additional capital, the absence of any material operating history or revenue, our ability to attract and retain qualified personnel, our ability to develop and introduce a new service and products to the market in a timely manner, market acceptance of our services and products, our limited experience in the industry, the ability to successfully develop licensing programs and generate business, rapid technological change in relevant markets, unexpected network interruptions or security breaches, changes in demand for current and future intellectual property rights, legislative, regulatory and competitive developments, intense competition with larger companies, general economic conditions, and other risks as described by us in Item 1.A “Risk Factors” in our most recent Form 10-K; other risks to which our Company is subject; other factors beyond the Company’s control.
All subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the foregoing. The Company has no obligation to and does not undertake to update, revise, or correct any of these forward-looking statements after the date of this report.
About REGO Payment Architectures, Inc.
REGO is a digital solution that enables children to stay safe in today’s tech-first environment. The REGO Digital Wallet platform allows parents and guardians to enable online shopping or digital spending at approved retailers, control what funds are available for which purchases, and reward children or pay allowance via the app. REGO is an innovative financial platform uniquely positioned due to its Children’s Online Privacy Protection Act (COPPA), California Consumer Privacy Act (CCPA), and General Data Protection Regulation (GDPR) compliance. Visit us at regopayments.com
Media Contact:
Kristin Graybill
One Kiln Marketing
[email protected]
(o) 302.536.2180
Artificial Intelligence
Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 30, 2024 /PRNewswire/ — The report titled “Clinical Trial Analytics Services Market by Services (Clinical Data Analytics, Clinical Trial Data Management, Clinical Trial Planning & Monitoring), Component (Data Management & Integrity Services, Data Visualization & Dashboarding, Patient Recruitment & Retention Analytics), Stages, End-User, Deployment – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $5.42 billion in 2023 to reach $11.95 billion by 2030, at a CAGR of 11.93% over the forecast period.
“Global Expansion and Technological Advancements in Analytics Services”
Clinical trial analytics services are revolutionizing the landscape of medical research and drug development across the globe by utilizing cutting-edge data analytics and statistical methodologies to offer invaluable insights from clinical trial data. These services enhance trial efficiency, streamline costs, and boost accuracy, enabling stakeholders to refine study protocols, improve patient recruitment measures, ensure participant safety, and conduct in-depth effectiveness studies. Such analytics are pivotal in supporting clinical development strategies, facilitating smoother regulatory approvals, and aiding in ongoing market surveillance and informed decision-making. Challenges such as data privacy concerns and the substantial investments required, the sector continues to grow, driven by an increasing focus on advancing drug discoveries and the sheer volume of clinical trials. The Americas lead the market with robust clinical trial activity, supported by Europe’s push for more transparent and unified trial regulations. Meanwhile, the Middle East is emerging as a key player with significant healthcare investments, and the Asia Pacific region is recognized for its cost advantages and substantial patient demographics, becoming an attractive locale for clinical research organizations (CROs) and pharmaceutical advancements. This global momentum towards personalized medicine and heightened technology integration signifies a promising future for clinical trial analytics services in enhancing the efficacy and outcomes of clinical trials worldwide.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trial-analytics-services
“Revolutionizing Clinical Trials through Analytics: A New Era in Drug Discovery”
The pharmaceutical market is witnessing a significant transformation, marked by an increased focus on developing treatments for a broader spectrum of diseases, including those once deemed untreatable. This shift has propelled the expansion of clinical trials, which are now more complex due to advanced technologies, the inclusion of varied patient demographics, and stringent regulatory standards. As a result, managing and analyzing the vast amounts of data from these clinical trials has become a daunting task. Enter clinical trial analytics services, a game-changing solution that streamlines the management of these trials. These services offer indispensable insights for making strategic decisions, facilitating patient recruitment, ensuring regulatory compliance, and evaluating market potential, ultimately speeding up the delivery of new therapies. With the pharmaceutical sector’s deep investment in the quest for innovative treatments, the pivotal role of clinical trial analytics services in enhancing efficiency and driving success in drug development is clearer than ever.
“Revolutionizing Drug Development: The Power of Clinical Data Analytics”
Clinical data analytics plays a pivotal role in transforming drug development by meticulously analyzing information gathered during clinical trials. This process is key to unlocking valuable insights that lead to better clinical decisions, enhanced trial efficiency, and faster path to market for new treatments. It effectively decodes patterns, forecasts results, and elevates patient care by watching over potential adverse impacts closely. The compilation of a wide variety of data, ranging from patient demographics, clinical outcomes, to biomarkers, underpins these analytics. Innovative technologies including machine learning and artificial intelligence are at the forefront of dissecting these complex data sets to offer understandable insights. The cornerstone of this endeavor is maintaining supreme data quality, ensuring the conclusions drawn are solid and dependable. Clinical trial data management plays an instrumental role, orchestrating the collection, integration, and validation of data throughout its lifecycle. This meticulous process involves designing data capturing systems, setting standards for data collection, and closely monitoring to uphold the integrity of data. Additionally, the blueprinting and vigilant monitoring of clinical trials are critical, demanding clear goals, precise sample sizes, and thorough oversight to guarantee trial integrity and participant safety. Engaging patients in the trial process further underscores the focus on patient-centered approaches, ensuring trials are not just about data but also about the individuals who make the research possible.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trial-analytics-services
“IQVIA Inc. at the Forefront of Clinical Trial Analytics Services Market with a Strong 10.57% Market Share”
The key players in the Clinical Trial Analytics Services Market include Laboratory Corporation of America Holdings, SGS S.A., QIAGEN N.V., ICON PLC, IQVIA Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trial Analytics Services Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trial Analytics Services Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trial Analytics Services Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trial-analytics-services
“Dive into the Clinical Trial Analytics Services Market Landscape: Explore 184 Pages of Insights, 574 Tables, and 26 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trial Analytics Services Market, by ServicesClinical Trial Analytics Services Market, by ComponentClinical Trial Analytics Services Market, by StagesClinical Trial Analytics Services Market, by End-UserClinical Trial Analytics Services Market, by DeploymentAmericas Clinical Trial Analytics Services MarketAsia-Pacific Clinical Trial Analytics Services MarketEurope, Middle East & Africa Clinical Trial Analytics Services MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trial-analytics-services
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030In Silico Clinical Trials Market – Global Forecast 2024-2030Clinical Trial Supplies Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo: https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trial-analytics-services-market-projected-to-reach-11-95-billion-by-2030—exclusive-report-by-360iresearch-302131960.html
Artificial Intelligence
Synthetik Applied Technologies LLC announces development of UrbanScale – a modeling platform for the prediction, characterization, and quantification of extreme urban heat
AUSTIN, Texas and LONDON, April 30, 2024 /PRNewswire/ — Synthetik Applied Technologies announces the development of UrbanScale, a tool to model and predict effects of extreme heat in urban areas, through a project funded by the National Oceanic and Atmospheric Association (NOAA). The physical characteristics of urban areas amplify heat effects resulting in what are known as urban heat islands — areas where surface temperatures are much higher than their surroundings. The UrbanScale tool addresses this climate peril with sophisticated analytic tools based on physics informed neural networks and cutting-edge machine learning to predict urban heat and help better understand and mitigate the risks associated with these extreme heat events. As a result of climate change, these events are expected to increase, impacting both the people that live in urban areas and the infrastructure on which they depend.
The UrbanScale platform shows significant promise to provide data on the severity of heat islands and their effects to better understand how they impact human health, energy use and damage to physical infrastructure. This information will provide a step-change in capability for government agencies, urban planners, and transportation authorities to direct efforts for mitigation and intervention. In particular, inclusion of demographic information into data pipelines will allow understanding of how urban heat effects may impact vulnerable or disadvantaged populations. Integration with climate forecasts and models will also provide unprecedented capabilities for forecasting risk associated with climate change.
Josh Hatfield, Director of Research and Development at Synthetik, said:
‘We are extremely grateful for the opportunity to study such an important issue. Extreme heat is already the largest cause of weather-related fatalities in the US, and climate change will only increase the importance of understanding heat in urban environments. Helping to meet that challenge fits directly into Synthetik’s mission.’
Synthetik COO Tim Brewer commented:
‘The UrbanScale tool will allow both our government and insurance partners to better characterize the risk of extreme heat in urban centers and promises to deliver critical insight on the way these events impact energy demands. We look forward to exploring its wide-ranging applications.’
Synthetik plans further development of UrbanScale with NOAA and other partners in the public and private sector.
For all inquiries: Contact Synthetik Applied Technologies PR [email protected]
Logo – https://mma.prnewswire.com/media/2067510/Synthetik_Applied_Technologies_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/synthetik-applied-technologies-llc-announces-development-of-urbanscale–a-modeling-platform-for-the-prediction-characterization-and-quantification-of-extreme-urban-heat-302132016.html
Artificial Intelligence
GLiNTECH – a Valiantys company, wins Atlassian Partner of the Year 2023 Services (APAC) award. Valiantys and GLiNTECH declared Finalists for Team Excellence and ITSM Solutions
PARIS, April 30, 2024 /PRNewswire/ — Atlassian announced today that GLiNTECH – a Valiantys company has won the Atlassian Partner of the Year 2023 Services (APAC) award. Valiantys and GLiNTECH were further declared finalists for the Team Excellence and ITSM Solutions awards, respectively.
This is an acknowledgement of their outstanding work for Atlassian customers during the calendar year 2023. This includes exceptional efforts in developing new business and driving innovative solutions for customer success.
“Our industry leading partners play a vital role in our customers’ continued success. We’re honored to highlight our top partners as award finalists this year, reflecting their ongoing commitment to delivering innovative solutions and unparalleled Atlassian services globally,” said Ko Mistry, Atlassian’s Head of Global Channels.
“We are delighted to be named as finalists for these awards from Atlassian, and we are particularly proud to celebrate GLiNTECH’s achievement in winning the Services (APAC) award.” said Emmanuel Benoit, Global Chief Executive Officer, Valiantys. “At Valiantys, embracing diversity of thought and challenging the ways our teams work has always provided Valiantys with a competitive edge to consistently deliver tangible results and value. We look to the future with unwavering determination and confidence as we continue to drive innovation and unlock potential for our customers around the globe.”
“We dedicate our IT Consulting Services and Custom Solutions to fulfilling our customers’ needs for success,” commented Dimitri Spyridopoulos, Chief Executive Officer GLiNTECH – a Valiantys company. “It’s an honor to be recognized by Atlassian as a finalist in two categories that reflect these efforts: Services and ITSM Solutions, and to be declared as winner for the Services award (APAC).”
For more information regarding this Press Release, contact: [email protected]
About Valiantys
Valiantys is a leading global consulting and services firm dedicated to Atlassian. The company accelerates business transformation by digitizing processes and modernizing teamwork, using the best agile methods and tools. Its Atlassian technical expertise is unparalleled and Valiantys supports its customers across the entire spectrum of projects on those platforms. As a recognized Agile at Scale, ITSM, and Cloud Specialized Partner, Valiantys help organizations accelerate time to value with Agile at scale, cloud, and ITSM implementations. Because teamwork requires more than just tools, the firm bridges the gap between applications and strategic practices such as SAFe® and ITIL. Over the last 15 years, Valiantys has helped more than 5,000 customers achieve their desired business outcomes at a reduced time to value, through improved team collaboration. More information about Valiantys can be found at https://www.valiantys.com/
About GLiNTECH – a Valiantys Company
GLiNTECH is a renowned Atlassian Platinum Partner headquartered in Australia and is the preferred choice for over 300 leading brands. The company has amassed more than 20 years of experience servicing enterprise clients across the Asia Pacific region, earning Atlassian Partner of the Year five times, including most recently for Professional Services. GLiNTECH is recognized as a Specialized Atlassian Cloud and ITSM partner. The company offers deep expertise in Licensing, Training, Support, Managed Services, Consulting, and Agile methodologies and has a proven record in providing reliable solutions while driving success within the Atlassian ecosystem. More information about GLiNTECH can be found here: https://www.glintech.com/
GLiNTECH was acquired by Valiantys in February 2024.
Photo – https://mma.prnewswire.com/media/2397508/GLiNTECH_2023_Services_award.jpg Logo – https://mma.prnewswire.com/media/1980997/Valiantys_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/glintech—a-valiantys-company-wins-atlassian-partner-of-the-year-2023-services-apac-award-valiantys-and-glintech-declared-finalists-for-team-excellence-and-itsm-solutions-302127386.html
-
Uncategorized6 days ago
Cherrypicks Partners with AWS DevAx Leading Cloud Technology Innovation for Hong Kong Enterprises
-
Artificial Intelligence5 days ago
Hikvision redefines urban mobility with AIoT-powered solutions at Intertraffic 2024
-
Artificial Intelligence5 days ago
HITACHI ACQUIRES MA MICRO AUTOMATION OF GERMANY IN EFFORT TO ACCELERATE GLOBAL EXPANSION OF ROBOTIC SI BUSINESS IN THE MEDICAL AND OTHER FIELDS
-
Artificial Intelligence5 days ago
Web O.No: Metaverse and Web 3.0 stunted by internet chaos, warn 87% of business leaders
-
Artificial Intelligence5 days ago
Greater efforts urged on sci-tech cooperation
-
Artificial Intelligence4 days ago
Cognitive Security Market Projected to Reach $134.26 billion by 2030 – Exclusive Report by 360iResearch
-
Uncategorized5 days ago
Xiao-I Corporation to Announce Full Year 2023 Results
-
Artificial Intelligence5 days ago
IBM, Government of Canada, Government of Quebec Sign Agreements to Strengthen Canada’s Semiconductor Industry